_choosing-sglt2-inhibitors-vs-glp-1-receptor-agonists-preview-1.jpg "Choosing SGLT2 Inhibitors vs GLP-1 Receptor Agonists from sgkt2 Video Screenshot Preview 1")
Gallery_choosing-sglt2-inhibitors-vs-glp-1-receptor-agonists-preview-3.jpg "Choosing SGLT2 Inhibitors vs GLP-1 Receptor Agonists from sgkt2 Video Screenshot Preview 3")
Gallery_choosing-sglt2-inhibitors-vs-glp-1-receptor-agonists-preview-hqdefault.jpg "Choosing SGLT2 Inhibitors vs GLP-1 Receptor Agonists from sgkt2 Video Screenshot Preview hqdefault")
GalleryPlay Video:
(Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
Jump To Video Parts
⏲ Duration: 7 minutes 43 seconds
👁 View: 7.3K times
Play Audio:👁 View: 7.3K times
Description:
Harvard Medical School Continuing Education
Harvard Medical School Continuing Education
Share with your friends:
Whatsapp | Viber | Telegram | Line | SMS
Email | Twitter | Reddit | Tumblr | Pinterest
Related Videos
_sglt2-inhibitors-in-chronic-kidney-disease.webp "Harvard Medical School Continuing Education")
_choosing-sglt2-inhibitors-vs-glp-1-receptor-agonists.webp "Harvard Medical School Continuing Education")
_sglt2-inhibitors-mechanism-of-action.webp "Nonstop Neuron")
_best-practices-for-starting-sglt2-inhibitors-in-hfpef-treatment.webp "Medscape")
_sglt2-inhibitors-are-associated-with-reduced-cv-disease-in-type-2-diabetes.webp "Mayo Proceedings")
⏲ 5 minutes 7 seconds 👁 171
_introduction-to-sglt2-inhibition.webp "Boehringer Ingelheim")
_sglt2-inhibitors-in-heart-failure-new-analyses-and-recent-updates.webp "Cátedra USC Semergen")
⏲ 1 hour 5 minutes 21 seconds 👁 1.6K
_sglt2-inhibitors-in-t1d-39people-are-using-them-now39.webp "Medscape")
_sglt2-inhibitors-in-chronic-kidney-disease.jpg)
_choosing-sglt2-inhibitors-vs-glp-1-receptor-agonists.jpg)
_sglt2-inhibitors-mechanism-of-action.jpg)
_best-practices-for-starting-sglt2-inhibitors-in-hfpef-treatment.jpg)
_sglt2-inhibitors-are-associated-with-reduced-cv-disease-in-type-2-diabetes.jpg)
_introduction-to-sglt2-inhibition.jpg)
_sglt2-inhibitors-in-heart-failure-new-analyses-and-recent-updates.jpg)
_sglt2-inhibitors-in-t1d-39people-are-using-them-now39.jpg)
![[+]](/images/menu.gif){kind=small}